chrisvoncsefalvay/vaers-outcomes huggingface dataset:
not getting any sleep; Involuntary movement of her arms and legs/body is just jerking; Felt like she was having an alien pop-out/felt like something in her body was squeezing her inside; Cataracts; This spontaneous case was reported by a consumer and describes the occurrence of CATARACT (Cataracts) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cataract extraction (on her right eye ) on 21-May-2021 and Cataract extraction (on the left eye ) on 06-May-2021. Concomitant products included MAGNESIUM and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced CATARACT (Cataracts) (seriousness criterion medically significant). On an unknown date, the patient experienced INSOMNIA (not getting any sleep), DYSKINESIA (Involuntary movement of her arms and legs/body is just jerking) and FEELING ABNORMAL (Felt like she was having an alien pop-out/felt like something in her body was squeezing her inside). The patient was treated with Surgery (Cataract surgery of right eye on 21MAY2021 and of left eye on 06MAY2021) for Cataract. At the time of the report, CATARACT (Cataracts) outcome was unknown and INSOMNIA (not getting any sleep), DYSKINESIA (Involuntary movement of her arms and legs/body is just jerking) and FEELING ABNORMAL (Felt like she was having an alien pop-out/felt like something in her body was squeezing her inside) had not resolved.            Treatment information was not provided.  The patient was scheduled to a neurologist.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However the patient's increased aged is also a risk factor for cataracts.   This case was linked to MOD-2021-185661 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However the patient's increased aged is also a risk factor for cataracts.
This case was reported by a lawyer and described the occurrence of mercury poisoning in a 5 year old male patient who received hepatitis B vaccine recombinant and diphtheria and tetanus toxoids and pertussis vaccine absorbed for prophylaxis. This report was received via the litigation process and a physician or other health care professional has not verified this report. At an unknown time after receiving hepatitis B vaccine, DTP/DTaP vaccine, Haemophilus vaccine, and/or MMR II vaccine, the patient experienced neurotoxic effects resulting in severe neurodevelopmental injuries. The events were attributed to mercury overdose and poisoning resulting from the thimerosal component of the vaccines. The multiple symptoms of the patient's injuries occurred and were first manifested no later than 1/1/01. According to the attorney, the patient incurred medical expenses and will continue to incur medical expenses in the future as a result of his injuries. The attorney also alleged that the patient suffered significant impairments in his ability to enjoy life, faces significant obstacles to performing the tasks and activities of everyday living, and suffers ongoing physical and mental distress. This case was assessed as medically serious (OMIC)
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 20-MAR-2017 at 12:44, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Soreness in upper arm at injection site, General fatigue, feeling chilled, other body aches, headache.
Thrombosis of lower left leg, Pain Level 10, Unable to stand and  walk for 35 minutes.  Pain continued for several weeks and i required a walker to support my movements around the house. treatment acetaminophen, Arnica Gel, Heating Pad, Vibration Stimulation, Light Leg exercise, blood thinner
Swelling, redness, tenderness.  Treated with cold compresses and Benadryl.
leg pain which made difficult for her to move - leg was very heavy; pain in the shoulder and neck; pain in the shoulder and neck; rash in the shoulder and neck; rash burned when she put something on it; canker sores in her mouth and gums; body aches - like the flu; stuffy nose; chills; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (rash burned when she put something on it), NASAL CONGESTION (stuffy nose), APHTHOUS ULCER (canker sores in her mouth and gums), PAIN (body aches - like the flu) and PAIN IN EXTREMITY (leg pain which made difficult for her to move - leg was very heavy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced NASAL CONGESTION (stuffy nose), PAIN (body aches - like the flu) and CHILLS (chills). On 27-Mar-2021, the patient experienced BURNING SENSATION (rash burned when she put something on it), APHTHOUS ULCER (canker sores in her mouth and gums), NECK PAIN (pain in the shoulder and neck), ARTHRALGIA (pain in the shoulder and neck) and RASH (rash in the shoulder and neck). On an unknown date, the patient experienced PAIN IN EXTREMITY (leg pain which made difficult for her to move - leg was very heavy). On 21-Mar-2021, NASAL CONGESTION (stuffy nose) had resolved. On 24-Mar-2021, PAIN (body aches - like the flu) and CHILLS (chills) had resolved. At the time of the report, BURNING SENSATION (rash burned when she put something on it), APHTHOUS ULCER (canker sores in her mouth and gums), PAIN IN EXTREMITY (leg pain which made difficult for her to move - leg was very heavy), NECK PAIN (pain in the shoulder and neck), ARTHRALGIA (pain in the shoulder and neck) and RASH (rash in the shoulder and neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Ultrasound scan: normal (normal) Ultrasound test came back clear.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       No concomitant medication was reported. Patient received Fluocinonide as treatment drug.
Diarrhea, rash on back, swelling in leg(knee and hip) occuring 3 days after immunization.
Dizzy, light-headed, reddening of the hands. 25mg of po benadryl administrated at 11:20am
2 cm erythematous, indurated lesion with burrowed ring of erythema, 5-6cm, on the posterior aspect of left arm, warm to touch, mild pain with palpation.
Patient received vaccine on 11Oct07.  Reported onset of swelling and tenderness to site beginning 12Oct07.  Reported for exam to physician in charge of vaccine program 15Oct07.  Swelling to left arm around vaccine injection site was approximately 2.5 cm in diameter, and raised approx 0.5cm in height.  Patient stated on 15Oct07 that his tenderness had resolved.  No orders for treatment were received from examining physician.  Patient returned to work witn instructions to apply hot moist compresses to speed resolution of swelling at site of what the physician diagnosed as a local reaction the the vaccination.
Breaking out in blisters. Three dermatologists visits. Prescription cream and one prednisone shot
First shot on June 12, 2018 was fine. Second shot on August 20, 2018 has had continual  low level pain at the site 24/7. Shot was given at pharmacy. I have contacted the pharmacy and my doctor.
Caller tested positive for covid-19; Caller tested positive for covid-19; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable consumer (patient) reported that female patient of an unspecified age received first dose of BNT162B2 (Lot number and expiry date not provided), via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  It was reported that the patient had first dose of the covid-19 vaccine on 17Dec2020 and she was tested positive for COVID-19 on 07Jan2021. She has not had her second dose, stated that MD said to wait 3 months because of antibodies, she would like information on what she should do. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 07Jan2021. The outcome of the events was unknown.    Information on the Lot/Batch Number has been requested.
patient got deathly ill; Initial information was received on 08-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer (patient).  This case involves a patient (unknown age and gender) who got deathly ill twice (illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got deathly ill twice (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There would be no information available on batch number for this case.
Experienced illness and symptoms of the following:  temporary loss of appetite and redness/tenderness where the shot was given.  Experienced a high fever over 103.  Additionally, experienced fatigue, ear burning sensation, severe headache and chills.   Note:  I didn't notify my primary physician.  Too ill during that time.
right sided weakness with nausea and vomiting resulting in a trip to the emergency room and then he was transferred to a larger hospital which resulted in hospital stay.
Headache for 48 hours, muscle and joint aches, extreme fatigue 48 hours, starting 5/20 6 am- swollen lymph under left arm (side of shot)-started today.   Had COVID August 26, 2020
pt recvd vax; exp uncontrollable screaming between naps & fever of 102.6;in er 4apr; no dx;12 hrs later appeared screaming reverted to intermittant whining; recovered
Developed Shingles.  Diagnosed by Primary Care provider; This is a spontaneous report from a contactable consumer, the patient. A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number- UNKNOWN) via an unspecified route of administration in left arm on 02Mar2021 at 14:30 (at an age of 60-years-old) as single dose for COVID-19 vaccination. Medical history included heart disease, unspecified from an unknown start date and unknown if continuing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient didnt have any allergies to medications, food, or other products. The patient didnt receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included AVODART, Statins (MANUFACTURER UNKNOWN), Blood pressure medicine (MANUFACTURER UNKNOWN); all taken for unknown indication from an unknown start date and unknown if ongoing. On 10Mar2021, the patient developed Shingles. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received included famciclovir (MANUFACTURER UNKNOWN) taken for Shingles from an unknown start date. The clinical outcome of Shingles was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.
expired vaccine of Menactra was given today, no AE; Initial information received on 20-Jul-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 17 year old female patient who received expired dose of vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (Expired product administered).  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medication was not reported.  No other vaccines were given the same visit.  On an unknown date, the patient received a dose of 0.5 mL (dosage interval: once) suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [lot U6208AD, expiry date: 08-Jul-2020] via intramuscular route at an unknown administration site for prophylactic vaccination.  It was a case of an actual medication error due to expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Started with soreness in the arm I received my shot about 6-7 days after. It progressed from soreness to pain in shoulder joint and weakness. Hard to do weightlifting and hard to sleep on it. Difficultly raising arm. The pain has not gone away at all, it fluctuates from bad to worse and back. Now it also radiates to just above the elbow in my arm.
A few days after the vaccine I noticed I was not feeling good and food was not taking good to me and I was having severe cramping. One day I was vomiting, and I didn't take anything for that. I have Irritable Bowel condition so I am very careful of what goes in my mouth. I spoke on the phone with a RNP and went in on a Monday morning one time for a blood draw. I can't give a specific date because I can't remember. I also had a UA done on that day and it showed elevated white blood cells on the blood test and they found blood in my UA and prescribed me Macrobid for 5 days. I didn't know I had a UTI because I didn't have any signs of it. I still have cramping, my abdominal track does not feel just right yet. I am going for a physical next month and that will be addressed.
my cousin died two days after getting his vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID: (Unknown).   A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "my cousin died two days after getting his vaccine". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.   Clinical Course: It reminded me of how my cousin died two days after getting his vaccine. Note: Unknown which vaccine the patient received.     The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: my cousin died two days after getting his vaccine
Fatigue, chills, malaise beginning night of vaccine; getting worse over two weeks and including night sweats. She had a slight rash a few days after vaccine.  After two weeks symptoms improved but still fatigued a month later with occasional night sweats. Week 3 developed pain over left eyebrow that continued for 2 weeks.
Twelve hours after vaccine my arm got red welts, was painful and itchy. Went away after 3 days. Could only take Tylenol as treatment. Two months after vaccine started having vaginal heavy bleeding with blood clots. Changed Fem Ring and it stopped. Then after two weeks the bleeding started again. Went to doctor and did biopsies in vagina and uterus, all pathology was normal. Now applying topical estrogen.
Evening of 4/30/21 - dizziness. increased appetite and food intake 5/1/21 - fatgue during the day  then sleptat least 16 hours straight, increased food intake
pt recv vax & 1hr p/that pt was waiting to be seated in a restaurant & had a syncopal episode or sz; BS in the field was 20-40;pt suffered a perforated Tm & facial trauma which is being followed by a dentist & ENT;
Developed redness, erythema, tenderness two days. Following SQ injection on left arm. Went to urgent care on 6/9/12 and was treated with Clindamycin x 10 days hospital on 6-15-12 and redness and tenderness was resolving.
On a 45 year old female pt received a dose Flu Shield on an unspecified date in November 2002. On an unspecified date in November, one day post-immunization, the pt developed an injection site reaction characterized by a "welt that lasted a few days." No additional info was available at the time of this report.
Flu like symptoms; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Feverish) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Feverish). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Feverish) outcome was unknown.            No concomitant medication were provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Causality with Humira was not reported.   This case was linked to MOD-2022-576606 (Patient Link).
Patient identified himself as 19 years of age and appropriate for vaccine at an offsite drive through mass immunization event . Upon returning to the clinic to enter the information into the computer it was found by the injector that the patient was actually 15 years and 8 months old rather than the 16 years required for the Pfizer COVID-19 vaccine.  No adverse problems from the vaccine administration. This RN called the mother of the patient and verified birthdate and informed her that he will not be eligible for the second dose until after he turns 16 years old. Mother verbalized understanding.
Patient got a rash on left deltoid, being stated in medical chart that she had a reaction to vaccines administered. Patient was seen in clinic by her PCP. Told to return to clinic if symptoms worsened.
Patient  was given the vaccine at 2 years of age and it is not indicated until the age of 4.
This spontaneous report as received from a physician refers to a male patient of unknown age. It was reported that in May 2012 the patient received the first dose in the GARDASIL (Lot number and expiration date not provided) (dose not provided, route intramuscular) vaccination series and the second dose in the GARDASIL vaccination series will be administered on 22-APR-2013. No adverse effect reported. Concomitant medications were not reported. Additional information has been requested.